Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2205-2210

  Yu, Vivian W L ^a   Ho, Wing Shing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Cell cycle; Huh 7; Inhibition; Tetrandrine

Indexed keywords

CASPASE; CASPASE 3; CASPASE 9; CYCLINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDES AND PROTEINS; PROTEIN BAX; PROTEIN BCL; PROTEIN P21; PROTEIN P53; SURVIVIN; TETRANDRINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRAIN HUH7; CONTROLLED STUDY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZYLISOQUINOLINES; CARCINOMA, HEPATOCELLULAR; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INHIBITORY CONCENTRATION 50; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84876248564     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2352     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P and Green DR: p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275: 7337?7342, 2000.
3. Chipuk JE, Maurer U, Green DR and Schuler M: Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4: 371-381, 2003. (Pubitemid 37491098)
4. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N: Noxa, a BH 3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000. (Pubitemid 30324238)
5. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS and Kroemer G: Apoptosis-inducing factor is involved in the regulation of caspase-independent cell death. J Cell Biol 158: 507-517, 2002. (Pubitemid 34851709)
6. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
7. Ng LT, Chiang LC, Lin YT and Lin CC: Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med 34: 125-135, 2006. (Pubitemid 43231407)
8. Yoo SM, Oh SH, Lee SJ, Lee BW, Ko WG, Moon CK and Lee BH: Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells. J Ethnopharmacol 81: 225-229, 2002.
9. He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim SH, Huang E, Gao Y, Yang K, Wagner ER, Wang L, Tang N, Luo J, Liu X, Li M, Bi Y, Shen J, Luther G, Hu N, Zhou Q, Luu HH, Haydon RC, Zhao Y and He TC: Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79: 211-219, 2011.
10. Liu C, Gong K, Mao X and Li W: Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer 129: 1519-1531, 2011.
11. Zhang Y, Wang C, Wang H, Wang K, Du Y and Zhang J: Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo. Cancer Lett 304: 21-32, 2011.
12. Yu J, Liu F, Sun M, Sun Z and Sun S: Enhancement of radio sensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine. Cancer Biother Radiopharm 26: 437-442, 2011.
13. 2- terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells: a possible Trojan strategy against cancer. Eur J Pharm Biopharm 75: 334-340, 2010.
14. Arnoult D, Parone P, Mattinou JC, Antonsson B, Estaquier J and Ameisen JC: Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in reponse to several proapoptotic stimuli. J Cell Biol 159: 923-929, 2002. (Pubitemid 36055747)
15. Susin SA, Daugas E and Ravagnan L: Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580, 2000.
16. Li X, Su B, Liu R, Wu D and He D: Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Sur Res 166: e45-51, 2011.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.